(Q45264286)

11 December 2017

title

An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease (English)

1 reference

11 December 2017

1 reference

Korzenik JR

1

1 reference

11 December 2017

Dieckgraefe BK

series ordinal

2

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Alimentary Pharmacology & Therapeutics

11 December 2017

published in

1 reference

11 December 2017

volume

21

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

391-400

1 reference

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02287.X

Pharmacoeconomic evaluation of high-dose chemotherapy and peripheral blood stem cell support in high-risk or poor-prognosis malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02287.X

An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02287.X

Neutrophil dysfunction in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02287.X

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02287.X

10.1111/J.1365-2036.2005.02287.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference